Linked Life Data

16025381

Source:http://linkedlifedata.com/resource/pubmed/id/16025381

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2005-7-18
pubmed:abstractText
This international meeting, co-sponsored by the National Health Research Institutes of Taiwan (NHRI) and the AmericanAssociation for Cancer Research (AACR), was dedicated to two pioneering scientists, Juei-Low Sung (Koo Foundation, Sun Yat-Sen Cancer Center, Taipei, Taiwan) and Kwang-Juei Lo (Taipei Veterans General Hospital, Taipei, Taiwan). The meeting focused on various aspects of viral hepatitis and hepatocellular carcinoma (HCC), and the relation between the two. Topics ranged from epidemiological studies, identification of environmental and genetic risk factors, mechanisms of pathogenesis, and research presentations on standard and novel treatment modalities. Highlights included discussions on adefovir dipivoxil (Gilead Sciences), emtricitabine (FTC; Triangle Pharmaceuticals), clevudine (L-FMAU; Triangle Pharmaceuticals/Abbott/Bukwang Pharmaceutical Industries), entecavir (Bristol-Myers Squibb), and especially L-isomer nucleoside analogs, for use in hepatitis B virus (HBV) therapy. Mention was also made of the potential roles of histamine and mycophenolic acid in the treatment of hepatitis C virus (HCV) infections, and of polyphenols and thalidomide for HCC.
pubmed:language
eng
pubmed:journal
pubmed:status
PubMed-not-MEDLINE
pubmed:month
Mar
pubmed:issn
1369-7056
pubmed:author
pubmed:issnType
Print
pubmed:volume
4
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
268-71
pubmed:year
2001
pubmed:articleTitle
AACR/NHRI Joint Conference: hepatitis and hepatocellular carcinoma: novel approaches.
pubmed:affiliation
University of Connecticut Health Center, Division of Gastroenterology - Hepatology, Room AM -044, 263 Farmington Avenue, Farmington, CT 06030-0001, USA. wu@nso.uchc.edu
pubmed:publicationType
Journal Article